Phase
Condition
Reproductive Health
Amenorrhea
Dysfunctional Uterine Bleeding
Treatment
myo-Inositol plus DIoscorea Villosa
Clinical Study ID
Ages 14-19 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- adolescent women aged 14-19 years old, with at least 3 years passed after menarche,and oligomenorrhea or amenorrhea
Exclusion
Exclusion Criteria:
Primary amenorrhea.
Hyperandrogenism due to other factors (i.e. adrenal hyperplasia or Cushingsyndrome).
Hyperprolactinemia or overt hypothyroidism (TSH ≥4).
Other hormonal alterations.
Ongoing hormonal therapies, including OCPs, six months before enrollment.
Ongoing pharmacological therapies.
Ongoing use of myo-Inositol supplement or other source of myo-Inositol, or Dioscoreavillosa, six months before enrollment.
Study Design
Study Description
Connect with a study center
Zhordania and Khomasuridze Institute of Reproductology
Tbilisi 611717, Georgia 0112
GeorgiaActive - Recruiting
Zhordania and Khomasuridze Institute of Reproductology
Tbilisi, 0112
GeorgiaSite Not Available
Agunco
Rome 3169070, Italy 00155
ItalyActive - Recruiting
Agunco
Rome, 00155
ItalySite Not Available
Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education
Saint Petersburg 498817, Russian Federation
RussiaActive - Recruiting
Department of Obstetrics and Gynecology with Reproductive Medicine, F.I. Inozemtsev Academy of Medical Education
Saint Petersburg,
Russian FederationSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.